Sitala Bio Ltd

This study tests an oral medication called STL303 in 300 adults aged 60 and older with geographic atrophy, a form of advanced dry age-related macular degeneration that causes a blind spot in central vision. The goal is to see if the drug can slow the death of light-sensing cells …

This study tests an experimental drug called STL303 for people with IgA nephropathy, a kidney disease. About 15 adults will receive either STL303 or a placebo to see if the drug is safe and can reduce protein in the urine, a sign of kidney damage. Possible side effects include na…